glp 1 agonists adverse effects drug side Managing Side Effects of GLP-1 Receptor – Transformation Weight Control Exploring the Side Effects of
Description
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early alzheimers disease with lecanemab, an anti-abeta protofibril antibody
32 It also significantly reduced the secondary composite HF endpoint (cardiovascular death, HF hospitalisation or urgent HF hospital visit), with an RRR of 18%
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program
Sellers, Y
